Literature DB >> 1684157

Functionally distinct subsets of human gamma/delta T cells.

C T Morita1, S Verma, P Aparicio, C Martinez, H Spits, M B Brenner.   

Abstract

To determine if effector subsets exist among human gamma/delta T cells, we examined the cytokine production and cytotoxic activity of gamma/delta T cell clones with different accessory molecule phenotypes, V delta and V gamma gene expression, and J gamma rearrangements. T cell clones bearing gamma/delta T cell receptor produce an array of cytokines like alpha/beta T cell clones. Individual gamma/delta T cell clones produced a characteristic array of cytokines without correlation with V delta or V gamma gene expression. However, when phenotypic subsets were considered, CD4+ gamma/delta clones produced significantly higher levels of interleukin 2 and granulocyte-monocyte colony-stimulating factor compared with CD4-CD8- and CD8+ gamma/delta clones. Similarly, when cytotoxic potential was assessed, CD4+ gamma/delta clones exhibited minimal activity when compared with CD4-CD8- and CD8+ adult peripheral blood gamma/delta clones. We conclude that functionally distinct gamma/delta T cell subsets exist and suggest that these subsets may correlate with expression of the CD4 accessory molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684157     DOI: 10.1002/eji.1830211215

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

Review 1.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

4.  Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.

Authors:  Hong Wang; Ghanashyam Sarikonda; Kia-Joo Puan; Yoshimasa Tanaka; Ju Feng; José-Luis Giner; Rong Cao; Jukka Mönkkönen; Eric Oldfield; Craig T Morita
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

5.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 6.  MicroRNAs are key regulators controlling iNKT and regulatory T-cell development and function.

Authors:  Li Zhou; Jang-June Park; Quanhui Zheng; Zheng Dong; Qingsheng Mi
Journal:  Cell Mol Immunol       Date:  2011-08-08       Impact factor: 11.530

Review 7.  Regulation of IgE Responses by γδ T Cells.

Authors:  Yafei Huang; Zhifang Yang; Jessica McGowan; Hua Huang; Rebecca L O'Brien; Willi K Born
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

8.  Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells.

Authors:  Kristin J Ness-Schwickerath; Chenggang Jin; Craig T Morita
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

9.  Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients.

Authors:  C Ueta; I Tsuyuguchi; H Kawasumi; T Takashima; H Toba; S Kishimoto
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Immunohistochemical study of gamma delta T cell receptor-positive cells in the capsular region of hepatocellular carcinoma: possible role in defense against expansion of carcinoma in the liver.

Authors:  K Chin; K Morise; K Kanayama; H Nagura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.